학술논문

CLINICAL ACTIVITY OF LONCASTUXIMAB TESIRINE PLUS IBRUTINIB IN NON‐HODGKIN LYMPHOMA: UPDATED LOTIS 3 PHASE 1 RESULTS.
Document Type
Article
Source
Hematological Oncology; Jun2021 Supplement S2, Vol. 39, p1-3, 3p
Subject
Language
ISSN
02780232